Evenamide Hydrochloride
- Generic Name
- Evenamide Hydrochloride
Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia
- First Posted Date
- 2020-07-08
- Last Posted Date
- 2021-05-20
- Lead Sponsor
- Newron Pharmaceuticals SPA
- Target Recruit Count
- 138
- Registration Number
- NCT04461119
- Locations
- ๐ฎ๐ณ
Sri Ramachandra Medical College, Department of Psychiatry, Chennai, Tamil Nadu, India
๐ฎ๐ณSt. John's Medical College Hospital, Koramangala, Karnataka, India
๐ฎ๐ณHelp Hospitals Clinical Research Department, Vijayawada, Andhra Pradesh, India
An Open Label, Single-Dose Study of 14C-NW-3509 in Healthy Male Subjects
Phase 1
- Conditions
- Healthy
- First Posted Date
- 2018-02-26
- Last Posted Date
- 2018-06-19
- Lead Sponsor
- Newron Pharmaceuticals SPA
- Target Recruit Count
- 6
- Registration Number
- NCT03446274
- Locations
- ๐ฌ๐ง
Quotient Sciences, Nottingham, NG, United Kingdom
A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia
- First Posted Date
- 2015-12-08
- Last Posted Date
- 2017-03-14
- Lead Sponsor
- Newron Pharmaceuticals SPA
- Target Recruit Count
- 90
- Registration Number
- NCT02624167
- Locations
- ๐บ๐ธ
Collaborative Neuroscience Network., Garden Grove, California, United States
๐ฎ๐ณKHM Hospital, Chennai, Tamil Nadu, India
๐ฎ๐ณTirthalli National Institute of Mental Health and Neurosciences, Bangalore, India
A Phase I- Sequential Cohort Dosing to Determine Maximum Tolerated Dose in Healthy Male Volunteers.
- First Posted Date
- 2013-10-07
- Last Posted Date
- 2017-06-20
- Lead Sponsor
- Newron Pharmaceuticals SPA
- Target Recruit Count
- 54
- Registration Number
- NCT01955564
- Locations
- ๐บ๐ธ
Collaborative Neuroscience Network-Clinical Pharmacology Unit, Long Beach, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2025. All Rights Reserved by MedPath